SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-058495
Filing Date
2023-07-20
Accepted
2023-07-20 16:06:18
Documents
43
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea181522-6k_nlspharma.htm 6-K 10190
2 COMPANY PRESENTATION ea181522ex99-1_nlspharma.htm EX-99.1 51944
3 GRAPHIC ex99-1_001.jpg GRAPHIC 80273
4 GRAPHIC ex99-1_002.jpg GRAPHIC 262765
5 GRAPHIC ex99-1_003.jpg GRAPHIC 529310
6 GRAPHIC ex99-1_004.jpg GRAPHIC 267415
7 GRAPHIC ex99-1_005.jpg GRAPHIC 251230
8 GRAPHIC ex99-1_006.jpg GRAPHIC 282235
9 GRAPHIC ex99-1_007.jpg GRAPHIC 288536
10 GRAPHIC ex99-1_008.jpg GRAPHIC 249130
11 GRAPHIC ex99-1_009.jpg GRAPHIC 245627
12 GRAPHIC ex99-1_010.jpg GRAPHIC 263473
13 GRAPHIC ex99-1_011.jpg GRAPHIC 289986
14 GRAPHIC ex99-1_012.jpg GRAPHIC 236825
15 GRAPHIC ex99-1_013.jpg GRAPHIC 296766
16 GRAPHIC ex99-1_014.jpg GRAPHIC 240775
17 GRAPHIC ex99-1_015.jpg GRAPHIC 257109
18 GRAPHIC ex99-1_016.jpg GRAPHIC 360798
19 GRAPHIC ex99-1_017.jpg GRAPHIC 355172
20 GRAPHIC ex99-1_018.jpg GRAPHIC 229482
21 GRAPHIC ex99-1_019.jpg GRAPHIC 259967
22 GRAPHIC ex99-1_020.jpg GRAPHIC 255497
23 GRAPHIC ex99-1_021.jpg GRAPHIC 377246
24 GRAPHIC ex99-1_022.jpg GRAPHIC 166433
25 GRAPHIC ex99-1_023.jpg GRAPHIC 262596
26 GRAPHIC ex99-1_024.jpg GRAPHIC 297670
27 GRAPHIC ex99-1_025.jpg GRAPHIC 286167
28 GRAPHIC ex99-1_026.jpg GRAPHIC 315632
29 GRAPHIC ex99-1_027.jpg GRAPHIC 230674
30 GRAPHIC ex99-1_028.jpg GRAPHIC 272731
31 GRAPHIC ex99-1_029.jpg GRAPHIC 235947
32 GRAPHIC ex99-1_030.jpg GRAPHIC 346594
33 GRAPHIC ex99-1_031.jpg GRAPHIC 206262
34 GRAPHIC ex99-1_032.jpg GRAPHIC 260515
35 GRAPHIC ex99-1_033.jpg GRAPHIC 329059
36 GRAPHIC ex99-1_034.jpg GRAPHIC 299913
37 GRAPHIC ex99-1_035.jpg GRAPHIC 192447
38 GRAPHIC ex99-1_036.jpg GRAPHIC 204000
39 GRAPHIC ex99-1_037.jpg GRAPHIC 300719
40 GRAPHIC ex99-1_038.jpg GRAPHIC 270873
41 GRAPHIC ex99-1_039.jpg GRAPHIC 65327
42 GRAPHIC ex99-1_040.jpg GRAPHIC 138390
43 GRAPHIC ex99-1_041.jpg GRAPHIC 79090
  Complete submission text file 0001213900-23-058495.txt   14718861
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 231099792
SIC: 2834 Pharmaceutical Preparations